Literature DB >> 7538075

Recombinant chicken interferon from Escherichia coli and transfected COS cells is biologically active.

U Schultz1, C Rinderle, M J Sekellick, P I Marcus, P Staeheli.   

Abstract

We have expressed a cDNA for virus-induced chick interferon in Escherichia coli. The product, a 19-kDa protein lacking the signal peptide, was purified to homogeneity from the bacterial inclusion bodies. Proteins in the insoluble fraction of bacterial lysates were dissolved in guanidine hydrochloride and subjected to chromatography on Q-Sepharose and MonoS columns. Purified recombinant chick interferon has a specific antiviral activity of approximately 10(8) IU/mg and is a powerful inducer of the interferon-responsive promoter of the chicken Mx gene. Culture medium of transfected COS cells expressing full-length chick interferon cDNA contained up to 5 x 10(4) IU antiviral activity/ml that could be neutralized by antibodies to purified recombinant chick interferon. The antibodies precipitated proteins of 23-28 kDa from the supernatants of transfected COS cells. Treatment with endoglycosidase F reduced the size of the immunoprecipitated proteins to approximately 20 kDa, demonstrating that chick interferon is a glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538075     DOI: 10.1111/j.1432-1033.1995.0073l.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  18 in total

1.  A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.

Authors:  Jirí Nehyba; Radmila Hrdlicková; Joan Burnside; Henry R Bose
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Mx is dispensable for interferon-mediated resistance of chicken cells against influenza A virus.

Authors:  Benjamin Schusser; Antje Reuter; Alexander von der Malsburg; Nicola Penski; Steffen Weigend; Bernd Kaspers; Peter Staeheli; Sonja Härtle
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  Species-independent bioassay for sensitive quantification of antiviral type I interferons.

Authors:  Thomas Kuri; Matthias Habjan; Nicola Penski; Friedemann Weber
Journal:  Virol J       Date:  2010-02-26       Impact factor: 4.099

4.  Possible involvement of the double-stranded RNA-binding core protein sigmaA in the resistance of avian reovirus to interferon.

Authors:  J Martínez-Costas; C González-López; V N Vakharia; J Benavente
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Highly pathogenic avian influenza viruses do not inhibit interferon synthesis in infected chickens but can override the interferon-induced antiviral state.

Authors:  Nicola Penski; Sonja Härtle; Dennis Rubbenstroth; Carsten Krohmann; Nicolas Ruggli; Benjamin Schusser; Michael Pfann; Antje Reuter; Sandra Gohrbandt; Jana Hundt; Jutta Veits; Angele Breithaupt; Georg Kochs; Jürgen Stech; Artur Summerfield; Thomas Vahlenkamp; Bernd Kaspers; Peter Staeheli
Journal:  J Virol       Date:  2011-05-25       Impact factor: 5.103

6.  Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts.

Authors:  R Hrdlicková; J Nehyba; H R Bose
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

7.  Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes.

Authors:  U Schultz; F V Chisari
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  Response of Three Different Viruses to Interferon Priming and Dithiothreitol Treatment of Avian Cells.

Authors:  Irene Lostalé-Seijo; José Martínez-Costas; Javier Benavente
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

9.  Transient expression of chicken alpha interferon gene in lettuce.

Authors:  Li Song; De-gang Zhao; Yong-jun Wu; Yi Li
Journal:  J Zhejiang Univ Sci B       Date:  2008-05       Impact factor: 3.066

10.  Super-sentinel chickens and detection of low-pathogenicity influenza virus.

Authors:  Philip I Marcus; Theodore Girshick; Louis van der Heide; Margaret J Sekellick
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.